We have been functioning for years to locate a way to take care of Alzheimer’s disease before sufferers develop dementia, and it’s really very interesting to be making programs to start the first of such trials later on this season. This project has the potential to significantly accelerate the speed of treatment and avoidance strategies for Alzheimer’s, said William Thies, PhD, the Alzheimer’s Association’s chief medical and scientific officer. We are convinced that helping to rapidly release the DIAN-Therapeutic Trials Unit will accelerate discovery of therapies that will change the span of the Alzheimer’s disease process and delay or quit the disease. Families signed up for the DIAN research have inherited types of Alzheimer’s that trigger dementia at a much earlier age than the even more common sporadic forms of the disease.On April 6, 2011, data from the PREGNANT study of PROCHIEVE to reduce the chance of preterm birth in ladies with premature cervical shortening were published by Ultrasound in Obstetrics and Gynecology. Sold U.S. Submitted the brand new Drug Program for PROCHIEVE to the U.S. Food and Medication Administration on April 26, 2011. ‘We are off to a solid start in 2011. To time, we’ve achieved three strategic goals: publication of PREGNANT study data in a peer-examined medical journal, the sale of U.S.